A revolutionary molecular profiling platform will transform precision health

Apton Biosystems develops a high-throughput and low-cost sequencing platform that will revolutionize the availability and affordability of genetic analysis. The platform will enable biomarker discovery, early disease detection and therapeutic monitoring, advancing preventive health and precision medicine.